School of Chemistry, University of Hyderabad, Hyderabad, Telangana, 500046, India.
School of Chemistry, University of Hyderabad, Hyderabad, Telangana, 500046, India.
Prog Biophys Mol Biol. 2019 Aug;145:52-64. doi: 10.1016/j.pbiomolbio.2018.12.004. Epub 2018 Dec 11.
Tuberculosis is one of the leading causes of death from bacterial infections. The multi-drug resistant strain has warranted the development of new drug molecules which can inhibit the growth of Mycobacterium tuberculosis (M.tb). Most of the known drugs inhibit the enzymes in the cell wall biosynthesis pathway. One such pathway is L-rhamnose, which involves four druggable enzymes RmlA, B, C and D. The 3D structure analyses of these protein models (RmlA, B and D) and crystal structure (RmlC) has been carried out. Multiple sequence alignments of homologs from distant species of 32 taxa and analyses of available structures were performed in order to study the conservation of sequence and structural motifs, and catalytically important residues. Based on these results and reported mechanism in other organisms, we have predicted putative catalytic mechanism of M.tb enzymes involved in the L-rhamnose biosynthesis pathway.
结核病是由细菌感染导致死亡的主要原因之一。耐多药菌株需要开发新的药物分子来抑制结核分枝杆菌(M.tb)的生长。大多数已知的药物抑制细胞壁生物合成途径中的酶。L-鼠李糖途径就是其中之一,它涉及四个可用药靶酶 RmlA、B、C 和 D。对这些蛋白模型(RmlA、B 和 D)和晶体结构(RmlC)进行了 3D 结构分析。对来自 32 个分类群的远缘种的同源物进行了多重序列比对,并对现有结构进行了分析,以研究序列和结构基序以及催化重要残基的保守性。基于这些结果以及其他生物体中的报道机制,我们预测了参与 L-鼠李糖生物合成途径的 M.tb 酶的假定催化机制。